文献速递临床试验与 GCP

评估口服牛磺酸补充对减重饮食肥胖女性空腹成纤维细胞生长因子、β-Klotho辅受体、部分生化指标及体成分的影响:双盲随机对照试验研究方案

Evaluation of the effect of oral taurine supplementation on fasting levels of fibroblast growth factors, β-Klotho co-receptor, some biochemical indices and body composition in obese women on a weight-loss diet: a study protocol for a double-blind, randomized controlled trial.
PubMed 文献 · Trials · 2019-05-31

本研究为8周双盲平行组随机对照试验,纳入50名18至49岁接受减重饮食的肥胖女性,评估口服牛磺酸补充对空腹血清FGFs、β-Klotho辅受体、部分生化指标及体成分的影响。作者认为牛磺酸可能调节脂肪组织来源因子,减重饮食可促进牛磺酸补充的有益效应,将首次评估二者联合对这些变量的影响。

要点

  • 8周双盲平行组随机对照试验,纳入50名18至49岁减重饮食肥胖女性。
  • 评估口服牛磺酸补充对空腹血清FGFs、β-Klotho辅受体、部分生化指标及体成分的影响。
  • 作者称将首次评估减重饮食联合牛磺酸补充对这些变量的影响。

核心结论

  • 作者认为牛磺酸可能调节脂肪组织来源因子,减重饮食可促进牛磺酸补充的有益效应,将首次评估二者联合对这些变量的影响。

研究设计与样本

  • 8周双盲、平行组、随机对照临床试验,纳入50名18至49岁接受减重饮食的肥胖女性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Taurine (Tau) is involved in many biochemical functions such as regulation of glucose and lipid metabolism, enhancement of energy expenditure, anti-inflammatory effects and appetite control. The most important effect of Tau in obesity is its direct effect on adipose tissue. Some evidence has shown an impaired FGF (fibroblast growth factor) 19 and 21 biosyntheses in obesity. Besides the effects of eicosapentaenoic acid on serum FGF concentrations, the effect of other nutrients on FGFs is not clear. Since obesity as an important health problem is rising around the world and on the other side, Tau biosynthesis is reduced by adipose-tissue-derived factors in obesity, the effects of Tau and a weight-loss diet on obesity need to be investigated further. METHODS: We will conduct an 8-week. double-blind, parallel-group, randomized controlled clinical trial to investigate the effect of Tau supplementation on fasting serum levels of FGFs, β-Klotho co-receptor, some biochemical indices and body composition in 50 obese women aged between 18 and 49 years on a weight-loss diet. DISCUSSION: We will determine the other advantages of a weight-loss diet on new metabolic risk factors. Since Tau may regulate adipose-tissue-derived factors and a weight-loss diet can promote the useful effects of Tau supplementation; for the first time, the effects of a weight-loss diet along with Tau supplementation on these variables will be assessed. TRIAL REGISTRATION: Iran Clinical Trials Registry, ID: IRCT20131125015542N2 . Registered on 24 November 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Haidari F, Asadi M, Mohammadi-Asl J, et al. Evaluation of the effect of oral taurine supplementation on fasting levels of fibroblast growth factors, β-Klotho co-receptor, some biochemical indices and body composition in obese women on a weight-loss diet: a study protocol for a double-blind, randomized controlled trial. Trials. 2019. PMID: 31151464. doi:10.1186/s13063-019-3421-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。